Share this post on:

Product Name :
Flecainide Acetate

Search keywords :
Flecainide (acetate)

drugId :
null

Target Vo:
Sodium channel alpha subunit

Target Vo Short Name :
SCNA

Moa_Name:
Sodium channel alpha subunit blockers

First Approval Country :
United States

First Approval Date Filter:
1985

Origin Company_Name :
Alvogen

Active Company_Name :
InCarda Therapeutics Inc

Active Indication_Name:
Atrial Fibrillation

In Active Indication_Name:
Coronary Disease

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
WDR77 Antibody (YA655)
Histone H3 Antibody
CD44 Antibody (YA801): CD44 Antibody (YA801) is a non-conjugated and Mouse origined monoclonal antibody about 82 kDa, targeting to CD44 (2H12). It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human.

Share this post on:

Author: Interleukin Related